am pleased to share our letter, highlighting that the science does not yet support regulatory approval of amyloid-targeting therapies for AD based solely on biomarker evidence.
alz-journals.onlinelibrary.wiley.com/doi/full/10....
am pleased to share our letter, highlighting that the science does not yet support regulatory approval of amyloid-targeting therapies for AD based solely on biomarker evidence.
alz-journals.onlinelibrary.wiley.com/doi/full/10....
Faculty of Psychology for Older People in @bpsofficial.bsky.social are thrilled to confirm Andy Bell, CEO for Centre for Mental Health as a keynote speaker for 2-3rd July 2025 conference, Lincoln. Registration & submissions open! Check out the details here: www.bps.org.uk/event/fpop-a...
Pleasure speaking with Erica Cotton for this @fndsociety.bsky.social podcast. Highlights include diagnostic paradigm shift in #FND, contextualizing rule in signs, emergency room considerations, program building, need for more education & mechanistic research.
www.buzzsprout.com/2216024/epis...
Definitely worth a look if you work with people living with #FND...
#Christmas can be a lovely time of year for some people, fairly mediocre for many, and awful for others.
Hope this helps...
Helloooo!👋
neuropsytools.com/pages/posts/...
Hello Blue Sky! First time posting here ☺️🏡
Second Blog Post! An introduction to visualising test scores in neuropsychology - because we all like pretty plots right...?
@donbps.bsky.social
Thank you!
At Anna Adlam's suggestion, please can I be added!
Ooo yes please! Thanks for the recommendation Anna